BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 31169523)

  • 1. Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
    Yokoda RT; Carey EJ
    Am J Gastroenterol; 2019 Oct; 114(10):1593-1605. PubMed ID: 31169523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel and emerging therapies for cholestatic liver diseases.
    Goldstein J; Levy C
    Liver Int; 2018 Sep; 38(9):1520-1535. PubMed ID: 29758112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obeticholic acid for the treatment of primary biliary cholangitis.
    Ali AH; Lindor KD
    Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies.
    Gerussi A; D'Amato D; Cristoferi L; O'Donnell SE; Carbone M; Invernizzi P
    Ann Hepatol; 2020; 19(1):5-16. PubMed ID: 31771820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Biliary Cholangitis: advances in management and treatment of the disease.
    Invernizzi P; Floreani A; Carbone M; Marzioni M; Craxi A; Muratori L; Vespasiani Gentilucci U; Gardini I; Gasbarrini A; Kruger P; Mennini FS; Ronco V; Lanati E; Canonico PL; Alvaro D
    Dig Liver Dis; 2017 Aug; 49(8):841-846. PubMed ID: 28546061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
    Stiehl A; Rudolph G; Sauer P; Theilmann L
    J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
    Hay JE
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Therapies for Chronic Cholestatic Liver Diseases.
    Wagner M; Fickert P
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():503-527. PubMed ID: 31506007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of cholestatic disease in 2017.
    de Vries E; Beuers U
    Liver Int; 2017 Jan; 37 Suppl 1():123-129. PubMed ID: 28052628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk stratification and treatment of primary biliary cholangitis.
    Martínez J; Aguilera L; Albillos A
    Rev Esp Enferm Dig; 2019 Jan; 111(1):63-70. PubMed ID: 30338693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
    Boberg KM; Schrumpf E
    Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic cholestatic liver diseases : Differential diagnosis, pathogenesis and current treatment in adults].
    Hohenester S; Beuers U
    Internist (Berl); 2017 Aug; 58(8):805-825. PubMed ID: 28721532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Old and new treatments for primary biliary cholangitis.
    Chascsa D; Carey EJ; Lindor KD
    Liver Int; 2017 Apr; 37(4):490-499. PubMed ID: 28371104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The medical management of primary sclerosing cholangitis.
    Cullen SN; Chapman RW
    Semin Liver Dis; 2006 Feb; 26(1):52-61. PubMed ID: 16496233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
    Linares Rodríguez A
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of cholestatic liver diseases].
    Gatzen M; Pausch J
    Med Klin (Munich); 2002 Mar; 97(3):152-9. PubMed ID: 11957790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Looking Into the Crystal Ball: Predicting Non-response to Ursodeoxycholic Acid in Primary Biliary Cholangitis.
    Zimmer V; Lammert F
    EBioMedicine; 2017 Feb; 15():10-11. PubMed ID: 28007481
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.
    Smith T; Befeler AS
    Curr Gastroenterol Rep; 2007 Mar; 9(1):54-9. PubMed ID: 17335678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and potential treatments for primary biliary cholangitis.
    Shah RA; Kowdley KV
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):306-315. PubMed ID: 31806572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and management of primary sclerosing cholangitis.
    Silveira MG; Lindor KD
    World J Gastroenterol; 2008 Jun; 14(21):3338-49. PubMed ID: 18528931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.